CV Sciences, Inc.
CVSI · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $8 | $7 | $6 | $6 |
| - Cash | $0 | $1 | $1 | $0 |
| + Debt | $1 | $1 | $2 | $1 |
| Enterprise Value | $8 | $7 | $7 | $7 |
| Revenue | $0 | $4 | $4 | $4 |
| % Growth | -100% | 0.4% | -7.2% | – |
| Gross Profit | $2 | $2 | $2 | $2 |
| % Margin | – | 50.9% | 46% | 43.2% |
| EBITDA | -$0 | -$0 | $0 | -$1 |
| % Margin | – | -2% | 2.6% | -15.9% |
| Net Income | -$0 | -$0 | -$0 | -$1 |
| % Margin | – | -7.2% | -3% | -18.7% |
| EPS Diluted | -0.002 | -0.001 | -0.001 | -0.004 |
| % Growth | -50% | -133.3% | 84.6% | – |
| Operating Cash Flow | $0 | $0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |